Trimetazidine, a Metabolic Modulator, Has Cardiac and Extracardiac Benefits in Idiopathic Dilated Cardiomyopathy

Circulation - United States
doi 10.1161/circulationaha.108.778019
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Potential Candidates for Cardiac Resynchronization Therapy in Japanese Patients With Idiopathic Dilated Cardiomyopathy

Circulation Journal
MedicineCardiovascular MedicineCardiology
2004English

Desmin Mutation Responsible for Idiopathic Dilated Cardiomyopathy

Circulation
Cardiovascular MedicinePhysiologyCardiology
1999English

Effect of a New Beta-Blocker, Nipradilol, on Cardiac Function and Neurohumoral Factors in Idiopathic Dilated Cardiomyopathy

Japanese Circulation Journal
1996English

Impaired Myocardial Metabolic Reserve and Substrate Selection Flexibility During Stress in Patients With Idiopathic Dilated Cardiomyopathy

American Journal of Physiology - Heart and Circulatory Physiology
Cardiovascular MedicinePhysiologyCardiology
2007English

Autoantibodies Against Beta-Adrenoceptors in Human Idiopathic Dilated Cardiomyopathy

Circulation Research
Cardiovascular MedicinePhysiologyCardiology
1989English

Treating Children With Idiopathic Dilated Cardiomyopathy (From the Pediatric Cardiomyopathy Registry)

American Journal of Cardiology
Cardiovascular MedicineCardiology
2009English

Idiopathic Dilated Cardiomyopathy in Children: Natural History and Predictors of Prognosis

European Journal of Heart Failure Supplements
2008English

Dystrophin Gene Abnormalities in Two Patients With Idiopathic Dilated Cardiomyopathy

Heart
Cardiovascular MedicineCardiology
1997English

Idiopathic Dilated Cardiomyopathy: Molecular Basis and Distilling Complexity to Advance

2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy